Mesenteric fat in Crohn's disease: A pathogenetic hallmark or an innocent bystander?

Gut

Volumn 56, Issue 4, 2007, Pages 577-583

  Peyrin Biroulet, Laurent ^a   Chamaillard, Mathias ^a   Gonzalez, Florent ^a   Beclin, Elodie ^a   Decourcelle, Cecilia ^a   Antunes, Laurent ^b   Gay, Jérôme ^a   Neut, Christel ^c   Colombel, Jean Frédéric ^a   Desreumaux, Pierre ^a  

^a INSERM   (France)

^b UNIVERSITÉ DE LORRAINE   (France)

^c UNIV LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ADIPORMONE; LEPTIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ATHEROSCLEROSIS; CROHN DISEASE; DISEASE MARKER; DROSOPHILA MELANOGASTER; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE; MESENTERY; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; WHITE ADIPOSE TISSUE;

ADIPOCYTES; ADIPOSE TISSUE, WHITE; CROHN DISEASE; HUMANS; HYPERTROPHY; MESENTERY;

EID: 34147213316     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2005.082925     Document Type: Review

References (74)

1. Lehrke M, Lazar MA. Inflamed about obesity. Nat Med 2004;10:126-7.
2. Kern PA, Saghizadeh M, Ong JM, et al. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 1995;95:2111-9.
3. Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004;92:347-55.
4. Yamashita S, Nakamura T, Shimomura I, et al. Insulin resistance and body fat distribution. Diabetes Care 1996;19:287- 91.
5. Pond CM. Adipose tissue, the anatomists' Cinderella, goes to the ball at last, and meets some influential partners. Postgrad Med J 2000;76:671-3.
6. Matarese G, Moschos S, Mantzoros CS. Leptin in immunology. J Immunol 2005;174:3137-42.
7. Zhang F, Basinski MB, Beals JM, et al. Crystal structure of the obese protein leptin-E100. Nature 1997;387:206-9.
8. Lord G. Role of leptin in immunology. Nutr Rev 2002;60:S35-8.
9. Mykoniatis A, Anton PM, Wlk M, et al. Leptin mediates Clostridium difficile toxin A-induced enteritis in mice. Gastroenterology 2003;124:683-91.
10. Siegmund B, Lehr HA, Fantuzzi G. Leptin: a pivotal mediator of intestinal inflammation in mice. Gastroenterology 2002;122:2011- 25.
11. Siegmund B, Sennello JA, Jones-Carson J, et al. Leptin receptor expression on T lymphocytes modulates chronic intestinal inflammation in mice. Gut 2004;53:965-72.
12. Gable DR, Hurel SJ, Humphries SE. Adiponectin and its gene variants as risk factors for insulin resistance, the metabolic syndrome and cardiovascular disease. Atherosclerosis 2006;188(2):231-44.
13. Nedvidkova J, Smitka K, Kopsky V, et al. Adiponectin, an adipocyte-derived protein. Physiol Res 2005;54:133-40.
14. Fayad R, Pini M, Sennello JA, et al. Role of adiponectin in DSS and TNBS induced colitis in mice. Gastroenterology 2006;130(Suppl 2):A550.
15. Steppan CM, Bailey ST, Bhat S, et al. The hormone resistin links obesity to diabetes. Nature 2001;409:307-12.
16. Pang SS, Le YY. Role of resistin in inflammation and inflammation-related diseases. Cell Mol Immunol 2006;3:29-34.
17. Patel L, Buckels AC, Kingdorn IJ, et al. Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem Biophys Res Commun 2003;300:472-6.
18. Bokarewa M, Nagaev I, Dahlberg L, et al. Resistin, an odipokine with potent proinflammatory properties. J Immunol 2005;174:5789-95.
19. Rondinone CM. Adipocyte-derived hormones, cytokines, and mediators. Endocrine 2006;29:81-90.
20. Koerner A, Kratzsch J, Kiess W. Adipocytokines: leptin - the classical, resistin - the controversial, adiponectin - the promising, and more to come. Best Pract Res Clin Endocrinol Metab 2005;19:525-46.
21. Vettor R, Milan G, Rossato M, et al. Review article: adipocytokines and insulin resistance. Aliment Pharmacol Ther 2005;22(Suppl 2):3-10.
22. Park HS, Park JY, Yu R. Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. Diabetes Res Clin Pract 2005;69:29-35.
23. Juge-Aubry CE, Henrichot E, Meier CA. Adipose tissue: a regulator of inflammation. Best Pract Res Clin Endocrinol Metab 2005;19:547-66.
24. Charriere G, Cousin B, Arnaud E, et al. Preadipocyte conversion to macrophage. Evidence of plasticity. J Biol Chem 2003;278:9850-5.
25. Lin Y, Lee H, Berg AH, et al. The lipopolysaccharide- activated Toll-like receptor (TLR)-4 induces synthesis of the closely related receptor TLR-2 in adipocytes. J Biol Chem 2000;275:24255-63.
26. Sewter CP, Digby JE, Blows F, et al. Regulation of tumour necrosis factor-alpha release from human adipose tissue in vitro. J Endocrinol 1999;163:33-8.
27. Batra A, Pietsch J, Stroh T, et al. TLR-specific cytokine production by preadipocytes and adipocytes - further evidence that adipose tissue is linked to innate immunity. Gastroenterology 2006;130(Suppl 2):A232.
28. Gay J, Tachon M, Neut C, et al. Mesenteric adipose tissue is colonized by bacterial flora and expresses pathogen recognition receptors in Crohn's disease. Gastroenterology 2005;128(Suppl 2):A503.
29. Hazan U, Romero IA, Cancello R, et al. Human adipose cells express CD4, CXCR4, and CCR5 [corrected] receptors: a new target cell type for the immunodeficiency virus-1? FASEB J 2002;16:1254-6.
30. Vangipuram SD, Sheele J, Atkinson RL, et al. A human adenovirus enhances preadipocyte differentiation. Obes Res 2004;12:770-7.
31. Dhurandhar NV, Israel BA, Kolesar JM, et al. Increased adiposity in animals due to a human virus. Int J Obes Relat Metab Disord 2000;24:989-96.
32. Vernochet C, Azoulay S, Duval D, et al. Human immunodeficiency virus protease inhibitors accumulate into cultured human adipocytes and alter expression of adipocytokines. J Biol Chem 2005;280:2238-43.
33. Carr A, Samaras K, Burton S, et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 1998;12:F51-8.
34. Sheehan AL, Warren BF, Gear MW, et al. Fat-wrapping in Crohn's disease: pathological basis and relevance to surgical practice. Br J Surg 1992;79:955-8.
35. Weakley FL, Turnbull RB. Recognition of regional ileitis in the operating room. Dis Colon Rectum 1971;14:17-23.
36. Smedh K, Olaison G, Nystrom PO, et al. Intraoperative enteroscopy in Crohn's disease. Br J Surg 1993;80:897-900.
37. Crohn BB, Ginzburg L, Openheimer GD. Regional ileitis: a clinical and pathological entity. JAMA 1932;99:1323-9.
38. Guillaume M. Defining obesity in childhood: current practice. Am J Clin Nutr 1999;70:126-30S.
39. Figueroa-Colon R, Mayo MS, Treuth MS, et al. Variability of abdominal adipose tissue measurements using computed tomography in prepubertal girls. Int J Obes Relat Metab Disord 1998;22:1019-23.
40. Keller C, Thomas KT. Measurement of body fat and fat distribution. J Nurs Meas 1995;3:159-74.
41. Desreumaux P, Ernst O, Geboes K, et al. Inflammatory alterations in mesenteric adipose tissue in Crohn's disease. Gastroenterology 1999;117:73-81.
42. Yamamoto K, Kiyohara T, Murayama Y, et al. Production of adiponectin, an anti-inflammatory protein, in mesenteric adipose tissue in Crohn's disease. Gut 2005;54:789-96.
43. Wulster-Radcliffe MC, Ajuwon KM, Wang J, et al. Adiponectin differentially regulates cytokines in porcine macrophages. Biochem Biophys Res Commun 2004;316:924-9.
44. Ajuwon KM, Spurlock ME. Adiponectin inhibits LPS-induced NF-kappaB activation and IL-6 production and increases PPARgamma2 expression in adipocytes. Am J Physiol Regul Integr Comp Physiol 2005;288:R1220- 5.
45. Saijo S, Nagata K, Nakano Y, et al. Inhibition by adiponectin of IL-8 production by human macrophages upon coculturing with late apoptotic cells. Biochem Biophys Res Commun 2005;334:1180-3.
46. Kobashi C, Urakaze M, Kishida M, et al. Adiponectin inhibits endothelial synthesis of interleukin-8. Circ Res 2005;97:1245-52.
47. Lappas M, Permezel M, Rice GE. Leptin and adiponectin stimulate the release of proinflammatory cytokines and prostaglandins from human placenta and maternal adipose tissue via nuclear factor-kappaB, peroxisomal proliferator-activated receptor-gamma and extracellularly regulated kinase 1/2. Endocrinology 2005;146:3334-42.
48. Tsatsanis C, Zacharioudaki V, Androulidaki A, et al. Adiponectin induces TNF-alpha and IL-6 in macrophages and promotes tolerance to itself and other proinflammatory stimuli. Biochem Biophys Res Commun 2005;335:1254-63.
49. Ogunwobi OO, Beales IL. Adiponectin stimulates proliferation and cytokine secretion in colonic epithelial cells. Regul Pept 2006;134:105-13.
50. Kojima S, Funahashi T, Maruyoshi H, et al. Levels of the adipocyte-derived plasma protein, adiponectin, have a close relationship with atheroma. Thromb Res 2005;115:483-90.
51. Ouchi N, Kihara S, Funahashi T, et al. Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation 2003;107:671-4.
52. Thompson H. Histopathology of Crohn's disease. In: Allan RN, Keighley MRB, Alexander-Williams J, et al, eds. Inflammatory bowel disease. New York: Churchill-Livingstone, 1990:263-85.
53. Vermeire S, Van Assche G, Rutgeerts P. The role of C-reactive protein as an inflammatory marker in gastrointestinal diseases. Nat Clin Pract Gastroenterol Hepatol 2005;2:580-6.
54. Gonzalez F, Rousseaux C, Dubuquoy L, et al. Expression of C-reactive protein in mesenteric adipose tissue in Crohn's disease. Gastroenterology 2006;130(Suppl 2):A29.
55. Colombel JF, Solem CA, Sandborn WJ, et al. Quantitative measurement and visual assessment of ileal Crohn's disease activity by CT enterography: correlation with endoscopic severity and C-reactive protein. Gut 2006;55:1561-7.
56. Barbier M, Vidal H, Desreumaux P, et al. Overexpression of leptin mRNA in mesenteric adipose tissue in inflammatory bowel diseases. Gastroenterol Clin Biol 2003;27:987-91.
57. Chen K, Li F, Li J, et al. Induction of leptin resistance through direct interaction of C-reactive protein with leptin. Nat Med 2006;12:425-32.
58. Shaw AJ, McLean KA, Evans BA. Disorders of fat distribution in HIV infection. Int J STD AIDS 1998;9:595-9.
59. Engelson ES, Kotler DP, Tan Y, et al. Fat distribution in HIV-infected patients reporting truncal enlargement quantified by whole-body magnetic resonance imaging. Am J Clin Nutr 1999;69:1162-9.
60. Pond CM. Long-term changes in adipose tissue in human disease. Proc Nutr Soc 2001;60:365-74.
61. Miller KK, Biller BM, Lipman JG, et al. Truncal adiposity, relative growth hormone deficiency, and cardiovascular risk. J Clin Endocrinol Metab 2005;90:768-74.
62. Farthing MJ, Campbell CA, Walker-Smith J, et al. Nocturnal growth hormone and gonadotrophin secretion in growth retarded children with Crohn's disease. Gut 1981;22:933-8.
63. Katznelson L, Fairfield WP, Zeizafoun N, et al. Effects of growth hormone secretion on body composition in patients with Crohn's disease. J Clin Endocrinol Metab 2003;88:5468-72.
64. Slonim AE, Bulone L, Damore MB, et al. A preliminary study of growth hormone therapy for Crohn's disease. N Engl J Med 2000;342:1633-7.
65. Klebl FH, Olsen JE, Jain S, et al. Expression of macrophage-colony stimulating factor in normal and inflammatory bowel disease intestine. J Pathol 2001;195:609-15.
66. Thomas AG, Holly JM, Taylor F, et al. Insulin like growth factor-I, insulin like growth factor binding protein-1, and insulin in childhood Crohn's disease. Gut 1993;34:944-7.
67. Itoh J, de La Motte C, Strong SA, et al. Decreased Bax expression by mucosal T cells favours resistance to apoptosis in Crohn's disease. Gut 2001;49:35-41.
68. Dubuquoy L, Dharancy S, Nutten S, et al. Role of peroxisome proliferator-activated receptor gamma and retinoid X receptor heterodimer in hepatogastroenterological diseases. Lancet 2002;360:1410-8.
69. Okuno A, Tamemoto H, Tobe K, et al. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J Clin Invest 1998;101:1354-61.
70. Vidal-Puig A, Jimenez-Linan M, Lowell BB, et al. Regulation of PPAR gamma gene expression by nutrition and obesity in rodents. J Clin Invest 1996;97:2553-61.
71. Vidal-Puig AJ, Considine RV, Jimenez-Linan M, et al. Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids. J Clin Invest 1997;99:2416-22.
72. Huang B, Dong Y, Mai W, et al. Effect of Chlamydia pneumoniae infection and hyperlipidaemia on the expression of PPARgamma, P50 and c-Fos in aortic endothelial cells in C57bL/6J mice. Acta Cardiol 2005;60:43-9.
73. Backhed F, Ding H, Wang T, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 2004;101:15718-23.
74. Gesta S, Bluher M, Yamamoto Y, et al. Evidence for a role of developmental genes in the origin of obesity and body fat distribution. Proc Natl Acad Sci U S A 2006;103:6676-81.